Cite
HARVARD Citation
Fukui, F. et al. (2020). Heregulin controls ERα and HER2 signaling in mammospheres of ERα-positive breast cancer cells and interferes with the efficacy of molecular targeted therapy. Journal of steroid biochemistry and molecular biology. p. . [Online].